The effect of a cationic porphyrin on Pseudomonas aeruginosa biofilms.
Current studies have indicated the utility of photodynamic therapy using porphyrins in the treatment of bacterial infections. Photoactivation of porphyrins results in the production of singlet oxygen ((1)O(2)) that damages biomolecules associated with cells and biofilms, e.g., proteins, polysaccharides, and DNA. The effect of a cationic porphryin on P. aeruginosa PAO1 biofilms was assessed by exposing static biofilms to 5,10,15,20-tetrakis(1-methyl-pyridino)-21H,23H-porphine, tetra-p-tosylate salt (TMP) followed by irradiation. Biofilms were visualized using confocal laser scanning microscopy (CLSM) and cell viability determined using the LIVE/DEAD BacLight viability assay and standard plate counts. At a concentration of 100 μM TMP, there was substantial killing of P. aeruginosa PAO1 wild-type and pqsA mutant biofilms with little disruption of the biofilm matrix or structure. Exposure to 225 μM TMP resulted in almost complete killing as well as the detachment of wild-type PAO1 biofilms. In contrast, pqsA mutant biofilms that contain less extracellular DNA remained intact. Standard plate counts of cells recovered from attached biofilms revealed a 4.1-log(10) and a 3.9-log(10) reduction in viable cells of wild-type PAO1 and pqsA mutant strains, respectively. Our results suggest that the action of photoactivated TMP on P. aeruginosa biofilms is two-fold: direct killing of individual cells within biofilms and detachment of the biofilm from the substratum. There was no evidence of porphyrin toxicity in the absence of light; however, biofilms pretreated with TMP without photoactivation were substantially more sensitive to tobramycin than untreated biofilms.
Collins
Tracy L
TL
Biology Department, University of Dayton, Dayton, OH 45469-2320, USA.
Markus
Elizabeth A
EA
Hassett
Daniel J
DJ
Robinson
Jayne B
JB
D001426:Bacterial Proteins / Q000378:metabolism; D018441:Biofilms / Q000187:drug effects*; D002412:Cations; D004269:DNA, Bacterial / Q000378:metabolism; D050296:Microbial Viability / Q000187:drug effects; D018613:Microscopy, Confocal; D017319:Photosensitizing Agents / Q000737:chemistry / Q000494:pharmacology; D011135:Polysaccharides, Bacterial / Q000378:metabolism; D011166:Porphyrins / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology*; D026082:Singlet Oxygen / Q000378:metabolism; D014031:Tobramycin / Q000494:pharmacology
C556154:5,10,15,20-tetrakis(1-methylpyridino)-21H,23H-porphine; D001426:Bacterial Proteins; D002412:Cations; D004269:DNA, Bacterial; D017319:Photosensitizing Agents; D011135:Polysaccharides, Bacterial; D011166:Porphyrins; D026082:Singlet Oxygen; D014031:Tobramycin